Quadrature Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Quadrature Capital's IDXX Position: Q2 2025 in Review
Quadrature Capital sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 3,774 shares — an estimated $1.58M sold.
Quadrature Capital first reported a position in IDXX in Q2 2015 and held it in 13 quarters. The position peaked at $21.1M in Q2 2022. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.
- Quadrature Capital reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
- Quadrature Capital sold 3,774 Idexx Laboratories shares in Q2 2025, an estimated $1.58M.
- Quadrature Capital first reported a position in Idexx Laboratories in Q2 2015 and held it in 13 quarters.
- Quadrature Capital's Idexx Laboratories position peaked at $21.1M in Q2 2022.
- 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.
Based on Quadrature Capital's 13F filing for Q2 2025, filed 13 Aug 2025.